Snell & Wilmer Advises Biotechnology Systems Company TARGAN Inc. in International Partnership with Couvoir Scott

SAN DIEGO – Snell & Wilmer advised TARGAN, Inc. (TARGAN), an AgTech company poised to transform animal protein production industries worldwide by bringing affordable, individualized care technologies to the market, in the first international partnership with Couvoir Scott of Quebec, Canada, a specialized and well-established company in the field of chick production for poultry producers. TARGAN’s mission to reshape animal health and protein production through innovative engineering, aligns well with Couvoir Scott’s dedication to quality and ethical practices. Together, the two entities will partner to expand their vision and role in animal protein production beyond borders, helping to propel the industry forward on an international level.

“Our partnership with Couvoir Scott marks a significant venture,” stated Ali Matloub, Director of Technical Sales and Business Development, International Markets in a recent press release. “This collaboration not only signals TARGAN’s entry into Canadian hatcheries but highlights our shared commitment to supplying high-quality chicks, prioritizing animal welfare and continuous research and development. We look forward to seeing how this partnership will lead to the advancement of the poultry industry in Canada.” 

TARGAN’s CEO, Ramin Karimpour, added, “I am incredibly excited about this first international contract. It represents a milestone in our journey to revolutionize the global animal protein production landscape. The collaboration with Couvoir Scott opens doors to new possibilities and is a testament to driving innovation on an international scale. This is just the beginning of what promises to be a transformative journey for TARGAN and our partners."

Bardia Moayedi served as lead counsel to TARGAN in advising on the international partnership. 

Snell & Wilmer's corporate and securities attorneys have served as counsel to a substantial number of clients ranging from Fortune 100 companies to smaller emerging businesses. Our attorneys have provided sophisticated legal representation to biotech companies, health care and financial institutions, public utilities, homebuilders, transportation companies, restaurant and hospitality providers, athletic complexes, fitness facilities and many other types of businesses. Snell & Wilmer’s venture capital and private equity practice covers multiple aspects of the transactional arena involving public and private companies, including the structuring and execution of majority buyouts and minority investments, acquisitions (including buy- and sell-side deals, as well as negotiated and auction deals), financings (including 144A transactions and PIPEs), going-private transactions, and spin-off transactions. Our venture capital and private equity attorneys advise both domestic and international funds, including venture capital, private equity, hedge, mezzanine, real estate opportunity, fund-of-funds, exchange, and other private investment funds.

About Snell & Wilmer
Founded in 1938, Snell & Wilmer is a full-service business law firm with more than 500 attorneys practicing in 16 locations throughout the United States and in Mexico, including Phoenix and Tucson, Arizona; Los Angeles, Orange County and San Diego, California; Denver, Colorado; Washington, D.C.; Boise, Idaho; Las Vegas and Reno, Nevada; Albuquerque, New Mexico; Portland, Oregon; Dallas, Texas; Salt Lake City, Utah; Seattle, Washington; and Los Cabos, Mexico. The firm represents clients ranging from large, publicly traded corporations to small businesses, individuals, and entrepreneurs. For more information, visit swlaw.com.